Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.

PubWeight™: 2.75‹?› | Rank: Top 1%

🔗 View Article (PMC 1171519)

Published in EMBO J on August 16, 1999

Authors

F J Oliver1, J Ménissier-de Murcia, C Nacci, P Decker, R Andriantsitohaina, S Muller, G de la Rubia, J C Stoclet, G de Murcia

Author Affiliations

1: UPR 9003 du Centre National de la Recherche Scientifique, 'Cancérogenèse et Mutagenèse Moléculaire et Structurale', Laboratoire Conventionné du Commissariat à l'Energie Atomique, Ecole Supérieure de Biotechnologie de Strasbo.

Articles citing this

(truncated to the top 100)

Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49

The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell (2010) 5.06

Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A (1999) 3.85

Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal (2011) 2.66

The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36

Bench-to-bedside review: Cytopathic hypoxia. Crit Care (2002) 2.29

Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A (2006) 2.07

Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell (2002) 2.05

Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev (2007) 1.86

Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci U S A (2002) 1.76

Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med (2009) 1.70

TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br J Pharmacol (2004) 1.62

Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med (2013) 1.62

Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol Cell Biol (2004) 1.61

Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc Natl Acad Sci U S A (2007) 1.58

Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol (2010) 1.46

ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol (2010) 1.43

Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. Cell Signal (2007) 1.35

Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem (2009) 1.32

Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet (2005) 1.30

Oxidative stress and accelerated vascular aging: implications for cigarette smoking. Front Biosci (Landmark Ed) (2009) 1.30

Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal (2005) 1.28

Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein. Nucleic Acids Res (2003) 1.26

Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc Natl Acad Sci U S A (2007) 1.23

PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res (2011) 1.23

PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J (2005) 1.19

Modulation of nucleosome-binding activity of FACT by poly(ADP-ribosyl)ation. Nucleic Acids Res (2006) 1.18

Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One (2009) 1.18

Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem J (2000) 1.18

Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest (2004) 1.17

Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol (2003) 1.16

Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc Natl Acad Sci U S A (2001) 1.15

IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo. J Exp Med (2010) 1.15

Poly(ADP-ribosyl)ation in mammalian ageing. Nucleic Acids Res (2007) 1.13

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nat Cell Biol (2006) 1.12

Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. Mol Cell (2015) 1.12

Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistance. Oncogene (2008) 1.09

TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch (2005) 1.08

Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology (2013) 1.08

RNA interference directed against Poly(ADP-Ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J Virol (2004) 1.07

Histone ADP-ribosylation facilitates gene transcription by directly remodeling nucleosomes. Mol Cell Biol (2012) 1.07

Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging. Aging (Albany NY) (2009) 1.05

Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury. J Immunol (2012) 1.04

Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury. Crit Care (2008) 1.04

Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J (2001) 1.02

gamma-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury. Free Radic Biol Med (2008) 1.02

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain (2010) 1.01

Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci U S A (2000) 1.01

Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines. Br J Cancer (2009) 1.01

Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology (2004) 1.00

Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury. Anesthesiology (2008) 1.00

Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acids Res (2004) 0.98

Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury. Mol Med (2003) 0.98

Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol (2005) 0.98

Increased susceptibility to streptozotocin-induced beta-cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice. Mol Cell Biol (2001) 0.97

Fine tuning the transcriptional regulation of the CXCL1 chemokine. Prog Nucleic Acid Res Mol Biol (2003) 0.96

Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids (2010) 0.96

Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling. J Cell Mol Med (2014) 0.95

Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol (2002) 0.94

Regulatory role of mitochondria in oxidative stress and atherosclerosis. World J Cardiol (2010) 0.94

Postnatal age influences hypoglycemia-induced poly(ADP-ribose) polymerase-1 activation in the brain regions of rats. Pediatr Res (2009) 0.94

NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene (2011) 0.93

Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes. Reprod Biol Endocrinol (2009) 0.92

Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J Immunol (2009) 0.92

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis? Cancers (Basel) (2013) 0.92

Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression. BMC Mol Biol (2006) 0.91

Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol (2006) 0.91

Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP. Mol Med (2011) 0.91

Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br J Pharmacol (2001) 0.90

Hippocampal poly(ADP-Ribose) polymerase 1 and caspase 3 activation in neonatal bornavirus infection. J Virol (2007) 0.90

Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1. Biochem J (2004) 0.90

Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid Med Cell Longev (2012) 0.90

Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med (2013) 0.89

Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB. Mediators Inflamm (2010) 0.88

Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells. J Interferon Cytokine Res (2010) 0.88

New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases. Chem Rev (2015) 0.88

Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response. PLoS One (2007) 0.87

Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion. FASEB J (2011) 0.87

PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis. J Biol Chem (2009) 0.87

Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. Am J Pathol (2007) 0.87

Re-evaluating PARP1 inhibitor in cancer. Nat Biotechnol (2011) 0.86

Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells. Clin Exp Immunol (2007) 0.86

PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-κB-mediated inflammatory response. PLoS One (2013) 0.86

Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1. Am J Pathol (2013) 0.86

Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther (2006) 0.85

Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines. J Leukoc Biol (2009) 0.85

AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6. Proc Natl Acad Sci U S A (2013) 0.85

Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. Int J Mol Med (2007) 0.85

The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol (2010) 0.83

Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. Br J Pharmacol (2005) 0.82

Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes (2013) 0.82

Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells. Biochem J (2005) 0.82

PCB-induced endothelial cell dysfunction: role of poly(ADP-ribose) polymerase. Biochem Pharmacol (2009) 0.81

Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion. Mol Med (2015) 0.81

Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model. Surgery (2010) 0.81

Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy. Nucleic Acids Res (2001) 0.80

Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene. J Am Soc Nephrol (2008) 0.80

The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis. Mediators Inflamm (2015) 0.79

Cytokine-mediated β-cell damage in PARP-1-deficient islets. Am J Physiol Endocrinol Metab (2012) 0.79

Articles by these authors

Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci U S A (1997) 5.24

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol (1998) 4.51

Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem (1998) 3.97

PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem (1999) 2.92

Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. Biochemistry (2000) 2.84

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol (2014) 2.84

Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83

Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res (2000) 2.81

High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol (1997) 2.59

The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43

Overproduction of the poly(ADP-ribose) polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in mammalian cells. EMBO J (1993) 2.38

Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure. Proc Natl Acad Sci U S A (1982) 2.37

The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci U S A (1990) 2.32

Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23

DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res (1998) 2.21

Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie (1999) 2.13

Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol (1986) 2.04

Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med (1998) 1.82

Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods (1985) 1.76

Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet (1999) 1.76

Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken. Proc Natl Acad Sci U S A (1996) 1.75

Poly(ADP-ribose)polymerase: a novel finger protein. Nucleic Acids Res (1989) 1.72

Identification by immunoprecipitation of cauliflower mosaic virus in vitro major translation product with a specific serum against viroplasm protein. EMBO J (1982) 1.69

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67

DNA ligase III is recruited to DNA strand breaks by a zinc finger motif homologous to that of poly(ADP-ribose) polymerase. Identification of two functionally distinct DNA binding regions within DNA ligase III. J Biol Chem (1999) 1.66

In vivo competition between self peptides and foreign antigens in T-cell activation. Nature (1988) 1.66

Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. J Exp Med (1998) 1.63

Sequence requirements for plasmid nuclear import. Exp Cell Res (1999) 1.63

Detection of papillomavirus DNA in human semen. Science (1986) 1.59

The human poly(ADP-ribose) polymerase nuclear localization signal is a bipartite element functionally separate from DNA binding and catalytic activity. EMBO J (1992) 1.57

Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. Biochemistry (1998) 1.56

Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53

Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol (1993) 1.51

A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. FEMS Microbiol Lett (1996) 1.49

Zinc-binding domain of poly(ADP-ribose)polymerase participates in the recognition of single strand breaks on DNA. J Mol Biol (1989) 1.49

The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem (1989) 1.46

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis (1996) 1.46

Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg (2001) 1.45

Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions. Stat Methods Med Res (2010) 1.42

Structural and functional analysis of poly(ADP ribose) polymerase: an immunological study. Biochim Biophys Acta (1988) 1.42

Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol (1997) 1.41

[Thoracoscopic video-assisted talcum pleurodesis (TTP)--effective treatment of malignant pleural effusion]. Zentralbl Chir (2002) 1.41

Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry (2011) 1.40

Use of self-retaining barbed suture for rectal wall closure in transanal endoscopic microsurgery. Tech Coloproctol (2014) 1.40

Conformational analysis of a 139 base-pair DNA fragment containing a single-stranded break and its interaction with human poly(ADP-ribose) polymerase. J Mol Biol (1994) 1.37

Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem (1991) 1.34

Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem (1986) 1.30

Detection of poly(ADP ribose) polymerase in crude extracts by activity-blot. Anal Biochem (1991) 1.30

The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis. J Mol Biol (1998) 1.28

The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys (1997) 1.26

Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic Acids Res (1998) 1.26

Electron microscopic studies of the different topological forms of the cauliflower mosaic virus DNA: knotted encapsidated DNA and nuclear minichromosome. EMBO J (1983) 1.26

Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Mol Cell Biol (2001) 1.25

Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol (2000) 1.25

Electron microscopic visualization of N-acetoxy-N-2-acetylaminofluorene binding sites in ColE1 DNA by means of specific antibodies. Proc Natl Acad Sci U S A (1979) 1.24

A bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA. structure and expression of the mouse PARP-2 gene. J Biol Chem (2000) 1.24

E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ (2009) 1.24

A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J (2001) 1.23

The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23

Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP-ribose)polymerase in Escherichia coli. Lysine 893 is critical for activity. J Biol Chem (1990) 1.22

Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr Res (2008) 1.22

Ionising radiation induces the expression of PARP-1 and PARP-2 genes in Arabidopsis. Mol Genet Genomics (2001) 1.21

Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res (1996) 1.20

Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension (2001) 1.19

Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J Cell Biol (2001) 1.19

Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr (1998) 1.19

Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol (1991) 1.19

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol (1999) 1.18

Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc Natl Acad Sci U S A (1994) 1.17

Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today (1999) 1.17

Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet (1999) 1.17

Immunity under the skin: potential application for topical delivery of vaccines. Vaccine (2003) 1.16

Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity. J Virol (1996) 1.15

Fpg protein of Escherichia coli is a zinc finger protein whose cysteine residues have a structural and/or functional role. J Biol Chem (1993) 1.15

Identification of potential active-site residues in the human poly(ADP-ribose) polymerase. J Biol Chem (1993) 1.15

Inhibition of poly(ADP-ribosyl)ation by overexpressing the poly(ADP-ribose) polymerase DNA-binding domain in mammalian cells. J Biol Chem (1990) 1.14

Superstructure and CD spectrum as probes of chromatin integrity. Nucleic Acids Res (1978) 1.14

Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching. Biochemistry (1997) 1.13

Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol (1991) 1.13